These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10963315)

  • 41. Cellular pharmacology of P-ethoxy antisense oligonucleotides targeted to Bcl-2 in a follicular lymphoma cell line.
    Gutiérrez-Puente Y; Tari AM; Ford RJ; Tamez-Guerra R; Mercado-Hernandez R; Santoyo-Stephano M; Lopez-Berestein G
    Leuk Lymphoma; 2003 Nov; 44(11):1979-85. PubMed ID: 14738153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colony formation of soft tissue sarcoma cells is inhibited by lipid-mediated antisense oligodeoxynucleotides targeting the human mdm2 oncogene.
    Meye A; Würl P; Bache M; Bartel F; Grünbaum U; Mansa-ard J; Schmidt H; Taubert H
    Cancer Lett; 2000 Feb; 149(1-2):181-8. PubMed ID: 10737722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication.
    Lavigne C; Yelle J; Sauvé G; Thierry AG
    AAPS PharmSci; 2001; 3(1):E7. PubMed ID: 11741258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Induction of apoptosis and inhibition of HL-60 cell proliferation by survivin antisense oligonucleotide].
    Zhu YS; Guo X; Ge J
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):97-100. PubMed ID: 16613698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
    Gryaznov S; Skorski T; Cucco C; Nieborowska-Skorska M; Chiu CY; Lloyd D; Chen JK; Koziolkiewicz M; Calabretta B
    Nucleic Acids Res; 1996 Apr; 24(8):1508-14. PubMed ID: 8628685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.
    Hu Q; Bally MB; Madden TD
    Nucleic Acids Res; 2002 Aug; 30(16):3632-41. PubMed ID: 12177306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liver.
    Robaczewska M; Guerret S; Remy JS; Chemin I; Offensperger WB; Chevallier M; Behr JP; Podhajska AJ; Blum HE; Trepo C; Cova L
    Gene Ther; 2001 Jun; 8(11):874-81. PubMed ID: 11423935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes.
    Mathew E; Hardee GE; Bennett CF; Lee KD
    Gene Ther; 2003 Jul; 10(13):1105-15. PubMed ID: 12808441
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
    Yang DC; Jiang XP; Elliott RL; Head JF
    Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.
    Watson PH; Pon RT; Shiu RP
    Cancer Res; 1991 Aug; 51(15):3996-4000. PubMed ID: 1855215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific inhibition of c-sis protein synthesis and cell proliferation with antisense oligodeoxynucleotides in human glioma cells.
    Nitta T; Sato K
    Neurosurgery; 1994 Feb; 34(2):309-14; discussion 314-5. PubMed ID: 8177392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA.
    Wickstrom EL; Bacon TA; Gonzalez A; Freeman DL; Lyman GH; Wickstrom E
    Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1028-32. PubMed ID: 3277186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide.
    Herbert JM; Guy AF; Lamarche I; Mares AM; Savi P; Dol F
    J Cell Physiol; 1997 Feb; 170(2):106-14. PubMed ID: 9009139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of human telomerase activity by antisense phosphorothioate oligonucleotides encapsulated with the transfection reagent, FuGENE6, in HeLa cells.
    Tamura Y; Tao M; Miyano-Kurosaki N; Takai K; Takaku H
    Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):87-96. PubMed ID: 10805159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of anchorage-independent growth of ras-transformed cells on polyHEMA surface by antisense oligodeoxynucleotides directed against K-ras.
    Kawada M; Fukazawa H; Mizuno S; Uehara Y
    Biochem Biophys Res Commun; 1997 Feb; 231(3):735-7. PubMed ID: 9070883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Growth inhibition of SK-MEL-30 human melanoma cells by antisense c-myc oligonucleotides delivered by poly(N-isopropylacrylamide)/ poly(ethyleneimine) copolymer.
    Dinçer S; Oskay EK; Piskin AK; Zeybek ND; Pişkin E
    J Tissue Eng Regen Med; 2010 Jun; 4(4):284-90. PubMed ID: 19967748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Daily addition of an anti-c-myc DNA oligomer induces granulocytic differentiation of human promyelocytic leukemia HL-60 cells in both serum-containing and serum-free media.
    Bacon TA; Wickstrom E
    Oncogene Res; 1991; 6(1):21-32. PubMed ID: 1997946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173.
    Smetsers TF; Skorski T; van de Locht LT; Wessels HM; Pennings AH; de Witte T; Calabretta B; Mensink EJ
    Leukemia; 1994 Jan; 8(1):129-40. PubMed ID: 8289478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
    Chavany C; Connell Y; Neckers L
    Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemically modified polysaccharide schizophyllan for antisense oligonucleotides delivery to enhance the cellular uptake efficiency.
    Matsumoto T; Numata M; Anada T; Mizu M; Koumoto K; Sakurai K; Nagasaki T; Shinkai S
    Biochim Biophys Acta; 2004 Jan; 1670(2):91-104. PubMed ID: 14738991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.